A detailed history of Manufacturers Life Insurance Company, The transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 23,588 shares of VNDA stock, worth $110,627. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,588
Previous 23,322 1.14%
Holding current value
$110,627
Previous $95,000 40.0%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$3.91 - $6.5 $1,040 - $1,729
266 Added 1.14%
23,588 $133,000
Q2 2023

Aug 11, 2023

BUY
$5.9 - $6.95 $8,401 - $9,896
1,424 Added 6.5%
23,322 $153,000
Q4 2022

Aug 11, 2023

SELL
$6.87 - $10.96 $185 - $295
-27 Reduced 0.12%
21,898 $161,000
Q4 2022

Feb 13, 2023

SELL
$6.87 - $10.96 $185 - $295
-27 Reduced 0.12%
21,898 $161,000
Q3 2022

Aug 11, 2023

SELL
$9.44 - $11.76 $5,267 - $6,562
-558 Reduced 2.48%
21,925 $216,000
Q3 2022

Nov 03, 2022

SELL
$9.44 - $11.76 $5,267 - $6,562
-558 Reduced 2.48%
21,925 $217,000
Q2 2022

Aug 11, 2023

SELL
$9.31 - $11.84 $4,673 - $5,943
-502 Reduced 2.18%
22,483 $245,000
Q2 2022

Aug 15, 2022

SELL
$9.31 - $11.84 $4,673 - $5,943
-502 Reduced 2.18%
22,483 $245,000
Q1 2022

Aug 11, 2023

BUY
$10.84 - $16.55 $11,783 - $17,989
1,087 Added 4.96%
22,985 $259,000
Q1 2022

May 20, 2022

SELL
$10.84 - $16.55 $60,606 - $92,531
-5,591 Reduced 19.57%
22,985 $260,000
Q4 2021

Feb 16, 2022

SELL
$15.69 - $21.14 $1,286 - $1,733
-82 Reduced 0.29%
28,576 $448,000
Q3 2021

Nov 12, 2021

SELL
$15.35 - $21.27 $43,010 - $59,598
-2,802 Reduced 8.91%
28,658 $491,000
Q2 2021

Aug 12, 2021

BUY
$15.71 - $21.51 $8,279 - $11,335
527 Added 1.7%
31,460 $677,000
Q1 2021

May 03, 2021

SELL
$13.42 - $20.28 $30,033 - $45,386
-2,238 Reduced 6.75%
30,933 $465,000
Q4 2020

Feb 12, 2021

BUY
$9.77 - $13.81 $8,695 - $12,290
890 Added 2.76%
33,171 $436,000
Q2 2020

Aug 10, 2020

SELL
$9.66 - $12.02 $15,282 - $19,015
-1,582 Reduced 4.67%
32,281 $362,000
Q1 2020

May 15, 2020

BUY
$7.5 - $16.8 $16,935 - $37,934
2,258 Added 7.14%
33,863 $351,000
Q4 2019

Feb 14, 2020

SELL
$12.38 - $17.47 $13,382 - $18,885
-1,081 Reduced 3.31%
31,605 $519,000
Q2 2019

Aug 14, 2019

SELL
$13.37 - $18.85 $1.65 Million - $2.33 Million
-123,599 Reduced 79.09%
32,686 $461,000
Q1 2019

May 13, 2019

BUY
$17.59 - $31.05 $2.19 Million - $3.86 Million
124,454 Added 390.98%
156,285 $2.88 Million
Q4 2018

Feb 14, 2019

SELL
$18.97 - $31.47 $30,940 - $51,327
-1,631 Reduced 4.87%
31,831 $832,000
Q3 2018

Nov 14, 2018

SELL
$18.25 - $23.0 $91,450 - $115,253
-5,011 Reduced 13.02%
33,462 $768,000
Q2 2018

Aug 14, 2018

BUY
$13.95 - $19.15 $72,009 - $98,852
5,162 Added 15.5%
38,473 $732,000
Q1 2018

May 15, 2018

SELL
$14.05 - $20.2 $12,462 - $17,917
-887 Reduced 2.59%
33,311 $562,000
Q4 2017

Feb 08, 2018

BUY
$12.85 - $18.1 $4,998 - $7,040
389 Added 1.15%
34,198 $519,000
Q3 2017

Nov 14, 2017

BUY
$15.4 - $18.85 $520,658 - $637,299
33,809
33,809 $605,000

Others Institutions Holding VNDA

About Vanda Pharmaceuticals Inc.


  • Ticker VNDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,561,500
  • Market Cap $265M
  • Description
  • Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...
More about VNDA
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.